Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Rybrevant Side Effects Center
Medically reviewed by Min Clinic Staff | Updated: January 2026
- Generic Name: amivantamab-vmjw for injection
- Brand Name: Rybrevant
- Drug Class: How Do Antineoplastic EGFR Inhibitors Work?, MET Tyrosine Kinase Inhibitors
Rybrevant (Amivantamab-vmjw for Injection) side effects drug center
Rybrevant Side Effects Center
What Is Rybrevant?
What Is Rybrevant?
Rybrevant (amivantamab-vmjw) is a bispecific EGF receptor-directed and MET receptor-directed antibody indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA- approved test, whose disease has progressed on or after platinum-based chemotherapy.
What Are Side Effects of Rybrevant?
Side effects of Rybrevant include:
- rash,
- infusion related reactions,
- Infection of the skin surrounding the fingernails or toenails,
- musculoskeletal pain,
- shortness of breath,
- nausea,
- fatigue,
- fluid retention (edema),
- inflammation of the mouth and lips,
- cough,
- constipation,